ImmunoPrecise Antibodies OverviewImmunoPrecise Antibodies Net Income
Profitability analysis for IPA.
Quarterly Net Income
-$3.87M
↑ 82.04% YoY
As of Jan 2026
Annual Net Income (TTM)
-$12.21M
↑ 73.52% YoY
Trailing 12 months ending Jan 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...